Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–77
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
≥18- and ≤77-years-old
Type 2 diabetes
Taking metformin immediate release (IR) or XR ≥1500 mg for at least 8 weeks as monotherapy
Glycosylated hemoglobin (A1C) ≥7% and ≤10%
Body mass index (BMI) ≤40 kg/m2
You may not be if
Women of childbearing potential unable or unwilling to use acceptable birth control
Women who are pregnant or breastfeeding
Significant cardiovascular history
Active liver disease
Renal impairment
Clareo Health | Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone
